NCT06803979 Impact of Delivery Method Elite Athletes.
| NCT ID | NCT06803979 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Faculty Hospital Kralovske Vinohrady |
| Condition | Delivery |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2025-03-16 |
| Primary Completion | 2040-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2025-03-16 with a primary completion date of 2040-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Labor itself can occur spontaneously vaginally, with the help of extraction methods, or via cesarean section. It can also be planned or awaited for the spontaneous onset of uterine contractions. Each method has its advantages and disadvantages regarding potential damage to the pelvic floor and its stability in vaginal delivery or extraction methods, or concerning the stability of the abdominal wall with subsequent wound healing after a cesarean section. The aim of the study is to retrospectively and prospectively determine the impact of the method of delivery on the performance of female athletes through a questionnaire study. Investigators would like to answer the question of whether cesarean delivery means a later return to training for athletes, whether pregnancy is problematic for female athletes in relation to their BMI, and whether pregnancy often signifies the end of a sports career for female athletes. The questionnaire also includes questions regarding overall women's health-menstrual cycle, incontinence, and mental health of female athletes. Prospectively, the questionnaire will be sent to all female athletes who meet representation limits once a year and for two years after retiring from the national team.
Eligibility Criteria
Inclusion Criteria: \- Elite female athletes meeting representation limits and included in national teams organized under the Czech Olympic Committee and individual sports federations. Exclusion Criteria: \- Any male
Contact & Investigator
Antonin Parizek, Prof., MUDr.
STUDY CHAIR
General Faculty Hospital in Prague
Frequently Asked Questions
Who can join the NCT06803979 clinical trial?
This trial is open to female participants only, studying Delivery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06803979 currently recruiting?
Yes, NCT06803979 is actively recruiting participants. Contact the research team at honza.zaple@seznam.cz for enrollment information.
Where is the NCT06803979 trial being conducted?
This trial is being conducted at Prague, Czechia.
Who is sponsoring the NCT06803979 clinical trial?
NCT06803979 is sponsored by Faculty Hospital Kralovske Vinohrady. The principal investigator is Antonin Parizek, Prof., MUDr. at General Faculty Hospital in Prague. The trial plans to enroll 500 participants.